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Abstract
Background: Insecticide-treated nets are the primary method of preventing malaria. To remain effective, the
pyrethroid insecticide must withstand multiple washes over the lifetime of the net. ICON® Maxx is a ‘dip-it-yourself’
kit for long-lasting treatment of polyester nets. The twin-sachet kit contains a slow-release capsule suspension of
lambda-cyhalothrin plus binding agent. To determine whether ICON Maxx meets the standards required by the
World Health Organization Pesticide Evaluation Scheme (WHOPES), the efficacy and wash fastness of ICON Maxx
was evaluated against wild, free-flying anopheline mosquitoes.
Methods: ICON Maxx was subjected to bioassay evaluation and experimental hut trial against pyrethroid-susceptible
Anopheles gambiae, Anopheles arabiensis and Anopheles funestus. Mosquito mortality, blood feeding inhibition and
personal protection were compared between untreated nets, conventional lambda-cyhalothrin treated nets (CTN) washed
either four times (cut-off threshold) or 20 times, and ICON Maxx-treated nets either unwashed or washed 20 times.
Results: In bioassay, ICON Maxx demonstrated superior wash resistance to the CTN. In the experimental hut trial, ICON
Maxx killed 75 % of An. funestus, 71 % of An. gambiae and 47 % of An. arabiensis when unwashed and 58, 66 and 42 %,
respectively, when 20 times washed. The CTN killed 52 % of An. funestus, 33 % of An. gambiae and 30 % of An. arabiensis
when washed to the cut-off threshold of four washes and 40, 40 and 36 %, respectively, when 20 times washed.
Percentage mortality with ICON Maxx 20 times washed was similar (An. funestus) or significantly higher (An. gambiae,
An. arabiensis) than with CTN washed to the WHOPES cut-off threshold. Blood-feeding inhibition with ICON Maxx 20
times washed was similar to the CTN washed to cut-off for all three species. Personal protection was significantly higher
with ICON Maxx 20 times washed (66-79 %) than with CTN washed to cut-off (48-60 %).
Conclusions: Nets treated with ICON Maxx and washed 20 times met the approval criteria set by WHOPES for Phase II
trials in terms of mortality and blood-feeding inhibition. This finding raises the prospect of conventional polyester nets
and other materials being made long-lastingly insecticidal through simple dipping in community or home, and thus
represents a major advance over conventional pyrethroid treatments.
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Background
Insecticide-treated nets (ITNs) are the most effective
and feasible means of preventing malaria in Africa south
of the Sahara [1]. Because conventional ITNs need to be
re-treated with pyrethroid insecticide at least once per
year to maintain their efficacy, several manufacturers of
nets have developed long-lasting insecticidal nets
(LLINs) in which wash-resistant formulation of insecti-
cide is coated or incorporated into the netting fibres
during production [2]. With good LLIN technology, in-
secticidal efficacy can be maintained against anopheline
mosquitoes for at least three years without need for fur-
ther re-treatment [2]. The advent of LLINs provided a
technical solution to the problem of low annual re-
treatment rates of conventional ITNs after initial distri-
bution and washing [3] and henceforth LLINs would be-
come the most important tool for malaria prevention in
Africa and Asia.
In 2005 the World Health Assembly (WHA) set a tar-
get of 85 % of those at risk of malaria should benefit
from preventive interventions by the end of 2015 [4].
This led to increased demand for LLINs by national mal-
aria control programmes (NMCPs) to meet the target of
at least 85 % protected by 2015, and led to international
donors opting for LLIN as their preferred choice of net
[5, 6]. The proportion of the population with access to
ITNs has increased markedly in sub-Saharan Africa over
the ten years since the WHA set the agenda. Based on
data from household surveys and reports on ITNs deliv-
ered by manufacturers and distributed by NMCPs, an
estimated 49 % of the population at risk had access to
an ITN in their household in 2013, compared to 3 % in
2004 [7]. Despite this achievement, not all households
have enough nets to meet family needs: an estimated
71 % of households have insufficient ITNs to protect all
household members and one-third of households do not
own even a single ITN [7]. More needs to be done to
reach all families with ITNs, and supply enough ITNs
for all household members [7].
While the main emphasis has been to treat LLINs dur-
ing manufacture, the majority of ITNs available through
the commercial retail sector are not LLINs and those
which are in use from this source have either never been
treated or were treated only on purchase [2, 8, 9]. Many
households still use locally sourced nets which are not
LLINs and which require regular re-treatment with in-
secticide, when insecticide becomes depleted after re-
peated washing. Thus, there is a need for a long-lasting
insecticide treatment kit which could convert untreated
nets into ITNs that can withstand repeated washing
without the need for re-treatment. Such an insecticide
kit could also be bundled with untreated nets on pur-
chase and enable local producers that lack LLIN manu-
facturing technology to produce an ITN which could
contribute usefully to malaria control and address local
LLIN shortages [2, 10].
Two brands of long-lasting treatment kit have so far
been developed: KO-Tab 1-2-3 developed by Bayer
Environmental Sciences [10] and ICON Maxx, devel-
oped by Syngenta [11]. ICON Maxx is based on the
slow-release capsule suspension (CS) formulation of
lambda-cyhalothrin that has previously been evaluated
by WHOPES and recommended for treatment of mos-
quito nets [12]. ICON Maxx is presented as a twin-
sachet pack, containing lambda-cyhalothrin 10CS and
binding agent, sufficient for the treatment of an individ-
ual polyester mosquito net. The target dose depends on
the net size and can range from 50 mg AI/m2 for a large
family-size net to 83 mg AI/m2 for a single-size net. A
safety assessment of ICON Maxx concluded that no un-
acceptable exposures were found in the preparation,
maintenance and use of the nets [12].
To determine whether ICON Maxx treated nets meet
the standards required by WHOPES, the efficacy and
wash fastness of ICON Maxx was evaluated in labora-
tory and field conditions against wild, free-flying anoph-
eline mosquitoes. This paper reports upon the Phase II
experimental hut evaluations undertaken in Tanzania by
the National Institute for Medical Research (NIMR) in
Muheza against Anopheles gambiae and Anopheles
funestus and by the Kilimanjaro Christian Medical
College (KCMCo) in Moshi against Anopheles arabiensis.
Together, these trials contributed to the WHOPES recom-
mendation for use of ICON Maxx as a long-lasting, wash-
resistant treatment for polyester mosquito nets.
Methods
Study areas and experimental huts
The study made use of experimental hut sites in two dis-
tricts of Tanzania: Muheza in Tanga region and Moshi
in Kilimanjaro region. The Muheza trial was conducted
at the NIMR field station at Zeneti village 5° 13’ S lati-
tude, 38° 39’ E longitude and 193 m altitude; where An.
gambiae s.s. and An. funestus are the major malaria vec-
tors [13]. Insecticide susceptibility tests carried out by
NIMR showed that the vector populations were 95-
100 % susceptible to alphacyano pyrethroids [14]. The
Moshi trial was conducted at the field site of KCMCo in
an area of rice irrigation 3° 23’ S latitude, 37° 20’ E longi-
tude and 800 m altitude; where An. arabiensis is the vec-
tor species. Insecticide susceptibility tests indicated
susceptibility to alphacyano pyrethroids [15].
The huts at both sites were constructed to a design de-
scribed by World Health Organization (WHO) [16]
based on the original verandah-hut design developed in
Tanzania [17, 18]. Modifications included a reduced eave
gap of 2 cm, a wooden ceiling, a roof of corrugated iron,
and a concrete floor surrounded by a water-filled moat.
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The huts had open eaves with verandah traps and win-
dow traps on each side. The working principle of these
huts has been described previously [19].
Net preparation and washing
ICON Maxx is a twin-sachet kit, with one containing
7.3 ml of lambda-cyhalothrin 10 % CS and the other
containing 7.7 ml of binding agent. The target dose of
lambda-cyhalothrin on a family size (130 × 180 ×
150 cm) polyester mosquito net is 55 mg AI/m2 (corre-
sponding to 1.55 g AI/kg for a 100-denier net). The ICON
Maxx kits and a white coloured 100-denier family-size
nets used in the study were supplied by Syngenta (Basel,
Switzerland). During treatment, the contents of both sa-
chets were mixed with 500 ml of water, sufficient to satur-
ate an individual polyester family-size net.
Conventionally treated family-size nets were treated
with lambda-cyhalothrin 2.5 % CS (Iconet®, Syngenta;
Basel, Switzerland) to a target dose of 15 mg/m2 recom-
mended by WHO [20]. To simulate wear and tear a total
of six 4 cm × 4 cm holes were cut into each net (two
holes on each side and one hole at each end). The long-
lasting insecticidal nets (LN) and conventional lambda-
cyhalothrin treated nets (CTN) were washed according
to WHOPES Phase II washing protocols [16]. Each net
was washed individually in 10 l of tap water containing
2 g/l of soap (‘Savon de Marseille’), subjected to 20 rota-
tions per min for 6 min during a 10 min immersion,
then rinsed twice. The interval between washes was one
day, which is the established regeneration time for ICON
Maxx [12]. The washing schedule was stepped to ensure
that the final wash of all treatment arms of the trial was
completed on the same day.
The CTN washed to the ‘point of insecticide exhaus-
tion’ served as a positive control against which to assess
ICON Maxx performance. The point of insecticide ex-
haustion or cut-off point, as defined by WHOPES, is the
number of washes at which the net causes less than
80 % mortality and 95 % knock-down in WHO cone bio-
assays conducted after each wash [16]. Determination of
the point of exhaustion was carried out by exposing un-
fed An. gambiae s.s. Kisumu in ten replicates of five
mosquitoes after each wash interval on the five panels of
the CTN. Exposure was for 3 min, knock-down was
scored after 60 min and mortality was scored 24 hr later.
The same procedure was adopted for a ICON Maxx
treated net to determine the number of washes which
ICON Maxx treatment causes less than 80 % mortality
and 95 % knock-down in WHO cone bioassays con-
ducted after each wash.
Experimental hut study design
The following five treatment arms were tested in the
huts: (i) unwashed ICON Maxx net, (ii) ICON Maxx net
washed 20 times, (iii) polyester net conventionally
treated with lambda-cyhalothrin at 15 mg/m2 and
washed four times, (iv) polyester net conventionally
treated with lambda-cyhalothrin at 15 mg/m2 and
washed 20 times, (v) untreated unwashed polyester net.
The primary outcomes were: (i) deterrence - the re-
duction in entry into treatment hut relative to the con-
trol huts (i.e., those containing untreated nets); (ii)
treatment induced exiting - the proportion of mosqui-
toes found in exit traps of treatment huts relative to the
same proportion in control huts; (iii) mortality - the pro-
portion of mosquitoes killed relative to the total catch
size; (iv) overall killing effect - the numbers killed by a
treatment relative to the untreated control, as derived
from the formula: Killing effect (%) = 100 (Kt-Ku)/Tu,
where; (i) Kt is the number killed in the huts with
treated nets, (ii) Ku is the number dead in the huts with
untreated nets, and (iii) Tu is the total entering the huts
with untreated nets; (v) blood-feeding inhibition - the
proportional reduction in blood feeding in huts with
treated nets relative to controls with untreated nets; and
(vi) personal protection - the reduction in mosquito bit-
ing by treated nets relative to untreated nets, as derived
from the formula: % Personal protection = 100 (Bu-Bt)/Bu,
where (i) Bu is the total number blood-fed mosquitoes in
the huts with untreated nets, and (ii) Bt is the total num-
ber blood-fed in the huts with treated nets.
Each morning dead and live mosquitoes were collected
from the verandahs, rooms and window traps. Live mos-
quitoes were provided with 10 % sugar solution. Delayed
mortality was recorded after 24 hours. Mosquitoes were
identified to species and gonotrophic status was re-
corded as unfed, blood-fed, semi-gravid, or gravid.
Experimental hut trials were conducted in Muheza
and Moshi to similar study design. Latin squares were
adopted to adjust for any variation between hut position,
volunteer sleeper attractiveness and individual nets. The
treatment arms were rotated once through each of the
huts: a treatment was assigned at random to a particular
hut for six (Muheza) or four (Moshi) nights of observa-
tion before being transferred to the next hut. Between
19:30 and 06:30 hours adult volunteers slept on beds
under the nets. The sleepers were rotated through the
huts on consecutive nights. Two to three nets were
available per treatment arm and each net was tested for
two nights during the four- or six-night rotation. At the
end of the rotation the huts were cleaned and aired for
one day before starting the next rotation. Data were col-
lected for 36 nights in the Muheza trial and for 24 nights
in the Moshi trial.
Random samples of An. gambiae s.l. from the huts
were identified to species by polymerase chain reaction
(PCR) [21]. Species identification recorded 100 % An.
gambiae s.s. from Zenet, Muheza (N = 60) and 100 %
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An. arabiensis from Lower Moshi (N = 60). Based on
these results all specimens collected in the hut trials
were recorded as An. arabiensis in Moshi and as An.
gambiae s.s. in Muheza.
The criterion for efficacy was that the ICON Maxx
washed 20 times should perform equal to or approxi-
mate number of washes a LLIN is likely to incur during
its lifetime.
Chemical analysis
The lambda-cyhalothrin content of ICON Maxx and
CTN nets used in the hut trials was estimated from net-
ting samples (four per net) cut before and after washing
according to WHO guidelines [15]. Lambda-cyhalothrin
was extracted using acetonitrile and injected onto high
performance liquid chromatography (HPLC) (Dionex
Summit, Surrey, United Kingdom), separated on a 120 Å
column, eluted with a 10 % acetonitrile aqueous solution
and passed through a PDA-100 detector at 275 nm.
From the calibration curve, the lambda-cyhalothrin con-
tent and the dosage per m2 was calculated.
Supporting bioassay tests on ICON Maxx nets and CTNs
used in the trials
Cone bioassays
Efficacy of ICON Maxx and CTN was assessed using
WHO cone bioassays after treatment, after completing
the washing cycles and at the end of the hut trials. Bio-
assay tests were conducted using a total of 50 An. gam-
biae Kisumu (pyrethroid susceptible), two to five days of
age, on five sections of the net as per WHO guidelines
in conditions of 25 ± 2 °C and 75 ± 10 % humidity. Mor-
tality was recorded 24 hours after exposure.
Tunnel tests
The tunnel tests were carried out on pieces of ICON
Maxx and CTN netting taking from the hut trials nets
after 0, 20 and 30 washes. The additional washing to 30
washes was to determine whether the long-lasting treat-
ment could withstand more than the standard 20
washes. The tests were conducted at the KCMCo Moshi
site using laboratory-reared An. arabiensis Doldotha
strain (pyrethroid susceptible).
The standard WHO tunnel test was modified by
inserting a transverse paper screen, with a 10 cm diam-
eter hole, across the mosquito release chamber between
the point of release and netting insert. The purpose was
to prevent mosquitoes from contacting the net except
after undertaking host orientation flights. Otherwise the
tunnel test apparatus was standard, being comprised of a
glass cylinder, 25 cm high, 21 cm wide, 60 cm long, di-
vided into two by a transverse insert made of test net-
ting. Nine 1 cm diameter holes were cut into the netting
to allow passage of mosquitoes to the bait chamber. In
the bait chamber, a guinea pig was housed uncon-
strained in a cage and in the release chamber 100 unfed
female mosquitoes aged five to eight days were released
at dusk and left overnight in conditions of 25 ± 2 °C and
80 ± 10 % humidity. The following morning the numbers
of mosquitoes found live or dead, fed or unfed in each
compartment were scored and delayed mortality re-
corded after a further 24 hours [16].
Ethics, consent and permission
Ethical clearance was obtained from the ethics committees
of the NIMR Tanzania (Ref: NIMR/HQ/R.8a/Vol X/86)
and London School of Hygiene and Tropical Medicine
(LSHTM). Written informed consent was obtained from
all volunteers participating in the study and each was pro-
vided with chemoprophylaxis and monitored daily for
fever or possible adverse events due to insecticide expos-
ure from the nets.
Statistical analysis
The main outcomes were the comparisons of efficacy of
the ICON Maxx unwashed and 20 times washed relative
to the CTN washed to cut-off in terms of the propor-
tions of mosquitoes blood-feeding or killed by the treat-
ments. Logistic regression analysis was used to estimate
proportional outcomes (mortality, blood-feeding, exit-
ing) and negative binomial regression was used to ana-
lyse counts of mosquitoes blood feeding (personal
protection) or dying (overall insecticidal effects) relative
to the untreated control, after adjusting for variation be-
tween individual sleepers and hut position. Laboratory
bioassay data was analysed using logistic regression.
Results
Determination of the cut-off number of washes for
conventional treated net
The cut-off point, sometimes known as the ‘point of in-
secticide exhaustion’, is the number of washes at which
cone bioassay mortality using An. gambiae Kisumu still
causes ≥80 % mortality [16]. At four washes, mortality
fell below the critical threshold with the CTN (Fig. 1)
meaning that lambda-cyhalothrin CTN washed three
times was the standard reference. With the ICON Maxx
treated net the mortality did not fall below the critical
thresholds until 26 washes.
Phase II - experimental hut trials
Mosquito entry and exiting from experimental huts
The numbers and proportion entering and exiting the
hut are shown in Table 1. During the trial in Muheza, 97
An. gambiae and 222 An. funestus were collected in the
control huts. Percentage deterrence of An. gambiae was
similar with treatments ICON Maxx unwashed or ICON
Maxx 20 times washed (58 vs 61 %) and these were not
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significantly different to CTN washed to the cut-off
point (41 %). Deterrence was lowest with the CTN
washed 20 times (12 %). With An. funestus, the deter-
rence effect was significantly higher with ICON Maxx
20 times washed compared with the CTN washed to
cut-off (66 and 25 %, respectively, P = 0.001). Deterrence
was negligible with the CTN washed 20 times (1.8 %).
During the trial in Moshi, 483 An. arabiensis were col-
lected in the control huts. No significant deterrent effect
was observed for any treatment arm.
Exiting rates of An. gambiae and An. funestus from
huts were high with untreated nets (81 and 90 %,
Fig. 1 Mortality of Anopheles gambiae Kisumu exposed in three-min cone bioassays to ICON Maxx LN and lamda-cyhalothrin CTN at 15 mg/m2
Table 1 Anopheline mosquitoes collected and exiting into verandah and window traps in the ICON Maxx experimental hut trials in
Muheza and Moshi, Tanzania in 2008
Untreated net ICON Maxx ICON Maxx CTN CTN
Number of washes 0 0 20 Cut-off 20
Anopheles funestus
Total females caught 222 122 76 167 218
Average catch per night 6.2a 3.4b 2.1b 4.6a 6.1a
% deterrence - 45 65.8 24.8 1.8
Total females exiting 200 106 71 164 200
% exiting 90.1a 86.9a 93.4a 98.2b 91.7a
Anopheles gambiae
Total females caught 97 41 38 57 85
Average catch per night 2.7a 1.1b 1.1b 1.6bc 2.4ac
% deterrence - 57.7 60.8 41.2 12.4
Total females exiting 79 34 33 56 75
% exiting 81.4a 82.9a 86.8a 98.3b 88.2a
Anopheles arabiensis
Total females caught 483 369 533 573 424
Average catch per night 20.1a 15.4a 22.2a 23.9a 17.7a
% deterrence - 23.6 0 0 12.2
Total females exiting 392 319 469 450 352
% exiting 81.2ac 86.4ab 88.0b 78.5c 83.0ac
Numbers in the same row sharing a letter superscript do not differ significantly (P >0.05)
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respectively). A significant insecticide-induced exophily
occurred for both species only with the CTN washed to
the cut-off point (P = 0.02 for An. gambiae and P = 0.003
for An. funestus). The majority of An. arabiensis (81 %)
exited the control huts during the night, and no
insecticide-induced exophily was apparent.
Mortality and overall killing effect
Percentage mortality by treatment is shown in Fig. 2 and
mortality corrected for control and overall killing effect
is shown in Table 2. With An. gambiae, mortality with
ICON Maxx treated nets was not significantly less at 20
washes (66 %) than at zero washes (71 %) (P = 0.95) and
was twice as high as the mortality observed with CTN
washed to cut-off point (33 %) (P = 0.001). Unwashed
ICON Maxx treated nets induced 75 % mortality of An.
funestus. The mortality of An. funestus was not signifi-
cantly higher with ICON Maxx washed 20 times com-
pared with the conventionally treated nets washed to the
cut-off point (58 and 52 %, respectively; P = 0.058). Dur-
ing the Moshi trial, the mortality of An. arabiensis with
ICON Maxx treated nets washed zero times (47 %) and
20 times (42 %) were significantly higher than the mor-
tality observed with conventionally treated nets washed
four and 20 times (30 %, 36 %). No significant difference
in mortality was observed between unwashed and
washed nets of either treatment. With the CTN 20 times
washed, considerable mortality was still observed across
all three species, ranging between 36 and 40 %.
As a significant deterrence effect was observed with
most treatments against An. gambiae and An. funestus,
the overall killing effect was usually less than the per-
centage mortality of mosquitoes collected from the huts
except with the CTN washed 20 times, which showed
no deterrence effect. The overall killing effect was simi-
lar across most treatments because there was a trade-off
between high mortality and high deterrence with the
ICON Maxx treatments and low mortality and low de-
terrence with the CTN treatments. As no significant de-
terrence effect was observed against An. arabiensis, the
overall killing effect and percentage mortality were quite
similar to each other. The majority of dead mosquitoes
were collected from window and verandah traps rather
than the room.
Blood feeding inhibition (BFI) and personal protection
Percentage blood feeding by treatment is shown in Fig. 3
and blood-feeding inhibition and personal protection is
shown in Table 2. In the Muheza trial, significant
blood-feeding inhibition was observed in both species
with ICON Maxx treated nets unwashed or 20 times
washed but BFI was generally less in An. funestus (48
and 28 %, respectively) than in An. gambiae (85 % and
47 % respectively). Blood-feeding inhibition of the
ICON Maxx treated nets 20 times washed was not sig-
nificantly different to that in the CTN washed to cut-
off against either An. funestus (28 vs 33 %, P = 0.247) or
An. gambiae (47 vs 11 %, P = 0.173). In the Moshi trial,
all insecticide treatments provided significant blood-
feeding inhibition (ranging from 53 to 70 %). Blood-
feeding inhibition for ICON Maxx treated nets 20 times
washed was similar to that of the conventionally treated
Fig. 2 Percentage mortality of Anopheles gambiae, Anopheles funestus and Anopheles arabiensis in experimental hut trials of ICON Maxx treated
nets and lambda-cyhalothrin CTN
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Table 2 Mortality and blood-feeding outcomes of anopheline mosquitoes collected in the ICON Maxx experimental hut trials in
Muheza and Moshi, Tanzania in 2008
Untreated net ICON Maxx ICON Maxx CTN CTN
Number of washes 0 0 20 Cut off 20
Anopheles funestus
Total dead 8 92 45 89 91
% mortality corrected for control 0a 74.6b 57.7bc 51.6c 39.6d
% overall killing effect 0a 37.8bc 16.7b 34.5c 37.4bc
Total blood-fed 81 23 20 41 88
% blood-feeding inhibition 0a 48.3b 27.9b 32.7b 0a
% personal protection 0ab 71.6c 75.3c 49.2ac 0b
Anopheles gambiae
Total dead 6 30 26 21 37
% mortality corrected for control 0a 71.4b 66.3b 32.7c 39.8c
% overall killing effect 0a 30.4b 25.3b 19b 39.2b
Total blood fed 48 3 10 25 34
% blood-feeding inhibition 0a 85.2b 46.8a 11.3a 19.2a
% personal protection 0a 93.8b 79.2bc 47.9ac 29.2a
Anopheles arabiensis
Total dead 15 181 233 183 160
% mortality corrected for control 0a 47.4b 41.9b 29.8c 35.7c
% overall killing effect 0a 34.4b 45.1b 34.8b 30b
Total blood fed 131 40 44 52 54
% blood-feeding inhibition 0a 60bc 69.6b 66.5bc 53c
% personal protection 0a 69.5b 66.4b 60.3b 58.8b
Numbers in the same row sharing a letter superscript do not differ significantly (P >0.05)
Fig. 3 Percentage blood feeding of Anopheles gambiae, Anopheles funestus and Anopheles arabiensis in experimental hut trials of ICON Maxx treated
nets and lambda-cyhalothrin CTN
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nets washed to the cut-off point (70 and 67 %,
respectively).
The personal protective effect against the biting An.
gambiae was 79 % with the ICON Maxx treated nets 20
times washed and 48 % with the CTN washed to cut-off
(P = 0.059). Against An. funestus, these values were 75
and 49 %, respectively (P = 0.114), and against An. ara-
biensis they were 66 and 60 %, respectively (P = 0.395).
Chemical analysis
The chemical analysis (Table 3) showed that mean
(±95 % CI) lambda-cyhalothrin content of ICON Maxx
and CTN samples was 59.7 ± 29 mg/m2 and 13.2 ±
6.1 mg/m2, respectively. Both means were close to the
target application rates of 55 mg/m2 and 15 mg/m2, re-
spectively. Twenty washes removed 48.5 % of lambda-
cyhalothrin from the ICON Maxx netting and 98.5 %
from the CTN. The lambda-cyhalothrin remaining on
the CTN washed to cut-off was 3.8 % (0.5 mg/m2) and
on ICON Maxx washed to cut-off (27 washes) it was
10.5 % (6.3 mg/m2).
Supporting bioassay tests on ICON Maxx nets and CTNs
used in the trials
Cone bioassay tests
ICON Maxx and lambda-cyhalothrin CTN nets were
tested by cone bioassay using An. gambiae Kisumu on
five sections of the net (n = 50) before washing, after
washing 20 times (before the trial) and after the hut trial.
Before washing, mortality was 100 % for both treat-
ments. After washing, the ICON Maxx and CTN in-
duced 88 and 50 % mortality, respectively, and at the
end of the trial they induced 92 and 12 %, respectively.
Tunnel tests
Tunnel tests using An. arabiensis Doldotha (pyrethroid
susceptible) strain on ICON Maxx and CTN netting
washed zero and 20 times are shown in Fig. 4. The pro-
portion penetrating the unwashed ICON Maxx and
CTN netting was less than 20 %, the proportion killed
was 100 % and the proportion blood-fed was less than
2 %. With 20 washes, the proportions penetrating the
ICON Maxx and CTN were 25 and 79 %, the propor-
tions blood feeding were 10 and 78 %, and the propor-
tions killed were 100 and 9 %, respectively. In all three
criteria ICON Maxx was significantly superior to the
CTN (p < 0.01).
Discussion
The Phase II experimental hut trials performed in
Tanzania on anopheline populations susceptible to
lambda-cyhalothrin (An. funestus, An. arabiensis and
An. gambiae) demonstrated that ICON Maxx induced
significantly higher mortality and similar rates of blood-
feeding inhibition compared to a conventional lambda-
cyhalothrin treated net washed to cut-off, and therefore
fulfilled the WHOPES criterion of a long-lasting insecti-
cidal treatment. In a further WHOPES-supervised Phase
II trial in Burkina Faso against a population of An. gam-
biae that was pyrethroid resistant the mortality induced
by unwashed Icon Maxx against free-flying mosquitoes
was less than 30 % compared to the 71 % mortality gen-
erated against the population in Tanzania, which were
susceptible [12]. Despite the high-level of pyrethroid re-
sistance (due to knock-down resistance frequency of 0.7-
0.9 and probably metabolic mechanisms too) in Burkina
Faso and the low mortality recorded in the trial, Icon
Maxx was shown to be superior to the CTN washed to
cut-off in the huts [12]. Given the efficacy and resistance
to washing of nets treated with ICON Maxx in both
studies, WHOPES recommended that an interim recom-
mendation be granted to ICON Maxx as a long-lasting
treatment [12]. The one caveat was the nets sampled in
Burkina Faso did show an unexpectedly high variation
both between and within nets and therefore WHOPES
concluded that given the heterogeneity in lambda-
cyhalothrin concentration on the surfaces of the nets,
ICON Maxx cannot be recognised as equivalent to a
WHOPES-recommended, factory-produced LLIN where
greater attention can be paid to quality assurance during
production. Because only a limited number of nets could
be analysed chemically in the Tanzania trial, it was not
possible to assess variation in application rate to the
same degree as in the Burkina Faso trial. Overall, the
lambda-cyhalothrin retention index after 20 washes in
the Tanzania and Burkina Faso trials was 51.5 and
28.2 %, respectively, and both of these were significantly
superior to the CTN retention index. Crucially, bio-
logical performance against free-flying anophelines did
not significantly deteriorate after 20 washes in either
trial and therefore any heterogeneity in concentration
across the surface of the net does not translate to a loss
of biological efficacy if mosquitoes are sampling a range
of insecticide concentrations across the surface as they
attempt to gain access to the host. A third experimental
hut trial was conducted with ICON Maxx in Côte
Table 3 Chemical analysis of lambda-cyhalothrin on the ICON
Maxx and CTN in the experimental hut trial in Muheza, Tanzania
in 2008
Number of washes Concentration of alpha-cypermethrin (mg/m2)
ICON Maxx CTN
0 59.7 ± 29.1 13.2 ± 6.1
4a - 0.5 ± 0.1
20 29.0 ± 18.3 0.2 ± 0.1
27b 6.3 ± 3.3 -
acut-off wash number for CTN
bcut-off wash number for ICON Maxx
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d'Ivoire in which over 60 % of free-flying An. gambiae
were killed but as the resistance status was undeter-
mined this result is difficult to put into context [22].
The WHOPES guidelines for testing of LN were re-
vised in 2013 to include as a positive control a
WHOPES-recommended LN with similar specifications
to the candidate LN in the type of insecticide, treatment
technique, netting material and wash number (0 and 20
times) [23]. LN manufacturers are not necessarily keen
to have their established LN product compared against
another LN and, by necessity, the reference LN often
needs to be obtained from the free market. Some recent
WHOPES trials have re-instated the CTN washed to
cut-off, in addition to the reference LN washed 20 times,
as a second comparison arm to check that the equiva-
lence/superiority of the reference LN is being main-
tained through quality assured production. The present
trial was undertaken before the revised guidelines were
introduced. In view of the quality assurance issues, it is
important to retain the CTN in WHOPES Phase II hut
trials as one of the positive control arms.
The laboratory biological and chemical assays con-
firmed that the ICON Maxx insecticide binding process
imparts strong wash-retention characteristics. The Phase
II washing regime stripped 96 % of the lambda-
cyholothrin from the conventionally treated net within
just a few washes as demonstrated by the surface con-
tent falling from 13.2 to 0.5 mg/m2 at cut-off and to
98 % reduction after 20 washes. And yet in hut trials the
CTN was still killing up to 40 % of all three species of
Anopheles after 20 washes. A similar finding was
observed in Phase II experimental hut trials of Inter-
ceptor LN, with the alpha-cypermethrin CTN washed 20
times killing between 40 % and 50 % of anophelines in
the hut trials [24]. The plausible explanation is that
alphacyano-pyrethroids, such as lambda-cyhalothrin and
alpha-cypermethrin, have strong binding affinity to poly-
ester filaments so that even after multiple washes a thin
layer of pyrethroid of less than 1 mg/m2, barely detect-
able by HPLC, must remain bound to the fibres and be
sufficiently bio-available to induce mortality in free-
flying mosquitoes in experimental huts. This explanation
is supported by the cone test results on CTN which
showed a 60 % decrease in mortality over the first four
washes and then little or no further decrease in mortality
in tests over the next 20 washes.
Lower rates of mortality were recorded in the huts
with An. arabiensis than with An. gambiae and An.
funestus. Differential mortality between these species has
been observed before with other types of pyrethroid in
other trials of ITNs [25]. Anopheles arabiensis is less
anthropophilic than An. gambiae and An. funestus and
the favoured hypothesis is that An. arabiensis is likely to
be less persistent at the surface of the net and more
likely to be repelled by the pyrethroid. There was no evi-
dence that An. arabiensis is more resistant to lambda-
cyhalothrin than An. gambiae or An. funestus or shows
differential response to ITN bioassay, as all three species
showed greater than 95 % mortality in 3-min cone tests
[25]. The lower mortality of An. arabiensis has been pro-
posed as a possible explanation for the species shift in
favour of An. arabiensis over An. gambiae, which has
Fig. 4 Tunnel test results with ICON Maxx and lambda-cyhalothrin CTN before and after washing against Anopheles arabiensis Doldotha pyrethroid
susceptible strain
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coincided with the universal coverage campaigns of
LLINs in Tanzania in recent years [26].
The demonstration of retention of efficacy and wash
fastness with ICON Maxx raises the prospect of long-
lasting pyrethroid treatment of textile materials other
than mosquito nets, such as curtains, canvas tents or
blankets either in or outside the factory. There is great
diversity in the fabrics and materials used for making
mosquito nets; insecticide-treated blankets, tents and
curtains have also shown protection against malaria in
trial settings [27–29]. The, as yet, unexplored question is
whether this formulation makes other types of material
long lasting. The efficacy and wash resistance of ICON
Maxx therefore needs to be confirmed on materials
made from other types of polymer such as cotton, nylon
and polyethylene before it can have the widest possible
application or impact against malaria.
In Phase III trials, recently completed, ICON Maxx
demonstrated efficacy criteria expected of long-lasting
net after 30–36 months of household use, whereas the
CTN fell short of the efficacy criteria within just
12 months of use [30]. WHOPES distinguishes between
long-lasting insecticide treatments that are carried out
in the community and LLINs that are produced in the
factory and expected to meet higher standards of quality
control and homogeneity of application [12]. The Phase
III trial of ICON Maxx, recently completed by NIMR/
LSHTM in Muheza, Tanzania, was the first demonstra-
tion of a long-lasting treatment, as opposed to a long-
lasting factory-treated net, providing efficacy and wash
fastness over the three-year expected lifetime of the net
[30]. The outcome of the present Phase II experimental
hut trial, with no significant loss of efficacy of ICON
Maxx between zero and 20 washes, successfully pre-
dicted the outcome of the three-year household trial.
Conclusion
Consequent to this Phase II experimental hut trial,
ICON Maxx obtained interim approval from WHO and
has since achieved full recommendation after Phase III
household trials. It is the first long-lasting treatment kit
to obtain full WHOPES recommendation.
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